One of common challenges at the early stage of biotech ventures is to calculate realistic estimates of the value of technologies to bring investment for lengthy commercialization process. The valuation should adequately account for the novelty of discovery, market size and opportunity, time and cost of development and risk that the investor must bear on each phase of product development.